Pancreatic Cyst Study Estimates Cancer Risk to Support Early Detection
Mayo Clinic researchers estimate three-year cancer risk in patients with pancreatic cysts,…
Personalized mRNA Therapy Shows Positive Phase 3 Results in Melanoma
Merck and Moderna report positive Phase 3 results for their personalized mRNA…
$80.5 Million Public Offering to Fund Development of Investigational Cancer Treatment
An $80.5 million public offering will support clinical trials, manufacturing and development…
Osara Health Calls for Cancer Support Beyond Treatment to Become Standard Care
Osara Health marks its 10th anniversary with a global call to make…
VANFLYTA® Commercialization Agreement Expands Access to AML Treatment in China
Innovent Biologics and Daiichi Sankyo enter an exclusive agreement to commercialize VANFLYTA®…
Lacutamab Advances Toward Phase 3 Trial in T-Cell Lymphoma
Sobi and Innate Pharma partner to advance lacutamab into a Phase 3…
Biotech Collaboration Aims to Advance Personalized Brain Cancer Therapy in Saudi Arabia
Northwest Biotherapeutics and SPIMACO have signed an MoU to explore the approval,…
Healthcare Group Reports AED2.79 Billion Revenue in H1 2026
Burjeel Holdings reported AED2.79 billion in H1 2026 revenue and over 3.7…
Cancer Institute Partners with US Medical School to Advance Oncology Education and Research
Burjeel Cancer Institute and Loyola University Chicago Stritch School of Medicine have…
FDA Grants Breakthrough Therapy Designation to Olomorasib for Advanced Pancreatic Cancer
The U.S. FDA has granted Breakthrough Therapy designation to Lilly's investigational KRAS…
